Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.

Drug metabolism and disposition: the biological fate of chemicals - 1 Nov 2008

Kim Dong-Hyun, Kim Keon-Hee, Kim Dae-Hwan, Liu Kwang-Hyeon, Jung Heung-Chae, Pan Jae-Gu, Yun Chul-Ho

Abstract excerpt

Recently, wild-type and mutant forms of bacterial cytochrome P450 BM3 (CYP102A1) have been found to metabolize various drugs through reactions similar to those catalyzed by human cytochromes P450 (P450s). Therefore, it has been suggested that CYP102A1 may be used to produce large quantities of th...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Proteins
Share to Coumarins
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to NADPH-Ferrihemoprotein Reductase

Share to Substrate Specificity

Source

Identifiers

PMID: 18669587
DOI: 10.1124/dmd.108.021220

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18669587-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.PMID 18669587Read ↗

Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites.Semantic proximity Read ↗

Generation of the human metabolite piceatannol from the anticancer-preventive agent resveratrol by bacterial cytochrome P450 BM3.Semantic proximity Read ↗

Drug metabolite generation using a laboratory evolved NADPH independent cytochrome P450: application of in vitro and in silico approaches.Semantic proximity Read ↗

Enhancement of 7-methoxyresorufin O-demethylation activity of human cytochrome P450 1A2 by molecular breeding.Semantic proximity Read ↗

Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450.Semantic proximity Read ↗

Stoichiometry of 7-ethoxycoumarin metabolism by cytochrome P450 2B1 wild-type and five active-site mutants.Semantic proximity Read ↗

P450(BM3) (CYP102A1): connecting the dots.Semantic proximity Read ↗

Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.Semantic proximity Read ↗

Identification of critical residues in novel drug metabolizing mutants of cytochrome P450 BM3 using random mutagenesis.Semantic proximity Read ↗

Epoxidation of perillyl alcohol by engineered bacterial cytochrome P450 BM3.Semantic proximity Read ↗

Exploring the potential of xenobiotic-metabolising enzymes as biocatalysts: evolving designer catalysts from polyfunctional cytochrome P450 enzymes.Semantic proximity Read ↗

Evaluation of alkoxyresorufins as fluorescent substrates for cytochrome P450 BM3 and site-directed mutants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.